The Effect of Micronutrient Supplementation on Nutrition Status and Well-being (NEXUS)

November 13, 2025 updated by: InnoNext Sarl

The Effect of Micronutrient Supplementation in Combination With Healthy Lifestyle Coaching on Nutrition Status and Well-being: A 6-Month Intervention Study in Ghana

Inadequate micronutrient status poses a significant challenge in Sub-Saharan African countries, including Ghana, and affects various demographics. The aim of the intervention study is to assess nutritional status and well-being through micronutrient supplementation with or without the combination of nutrition training and healthy lifestyle coaching among young adults in Ghana.

The outcomes the study is assessing are:

PRIMARY OUTCOME:

The primary outcome of this study is to determine if micronutrient supplement improves the vitamin D status of the study participants with or without additional Nutrition Training and Healthy Lifestyle Coaching. Vitamin D status will be assessed as serum 25(OH) D in serum.

SECONDARY OUTCOMES:

The secondary objectives are to:

  1. determine if the provision of micronutrient supplement with or without additional NuTHLiC improves participants serum levels of vitamin B12, serum zinc, serum magnesium, serum ferritin and red blood cell Hb.
  2. Assess the effect of micronutrient supplement with or without additional NuTHLiC on participants lifestyle habits and overall well- being through targeted questionnaires.

TRIAL DESIGN: This study is a 3-arm blinded randomized placebo-controlled trial among 151 young adults

participants in Arm 1 receive a daily Investigational Product and attend nutrition training and healthy lifestyle coaching;

participants in Arm 2 will receive an active Investigational Product;

participants in Arm 3 will receive a placebo Investigational Product.

Main data collection, including blood sampling for nutritional status will take place at Baseline (Day 0), Midpoint (Month 3) and Endpoint (Month 6). In addition, all participants will fill in a digital diary.

Study Overview

Detailed Description

This study is a 6-month intervention study to assess the effect of micronutrient supplementation in combination with healthy lifestyle coaching on nutrition status and well-being will improve nutritional status with or without the combination of nutrition training and healthy lifestyle coaching among young adults in Ghana.

The test product is an Effervescent powder that is Orange flavored containing multiple vitamins and minerals, in a single serving, packaged within a multi-layer structure foil sachet. Participants will be required to mix Effervescent powder with water before consumption.

The placebo is also an Effervescent powder that is Orange flavored, but without active components, packaged within a multi-layer structure foil sachet. The placebo will be packaged in a manner that it looks and feels just like the micronutrient supplement with the only difference being the absence of the active ingredient in the micronutrient supplement.

The primary outcome of this study is to determine if micronutrient supplement improves the vitamin D status of the study participants with or without additional Nutrition Training and Healthy Lifestyle Coaching (herein referred to as NuTHLiC), Vitamin D status will be assessed as serum 25(OH) D in serum.

The secondary objectives are to:

  1. determine if the provision of micronutrient supplement with or without additional NuTHLiC improves participants serum levels of vitamin B12, serum zinc, serum magnesium, serum ferritin and red blood cell Hb.
  2. Assess the effect of micronutrient supplement with or without additional NuTHLiC on participants lifestyle habits and overall well-being through targeted questionnaires

After consenting, blood samples will be taken for biochemical analyses and the participants will also be assessed through standardized questionnaires in addition to vitals and anthropometric measurements.

The primary analysis will be intention-to-treat analysis. We fit a linear mixed effect model involving a random effect of participants within treatment groups and fixed effects of time and their interactions. The treatment effects will be shown as the mean difference (95% CI) in the change in serum 25(OH)D concentration between intervention and control groups. Model assumptions will be checked by inspecting the residual and quantile-quantile plot. Difference-in-difference (DID) will be used to determine the effect of each micronutrient supplement between the treatment (intervention) groups and the control (placebo) group. Sub-group analysis will also be used to contrast the factorial analysis.

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Volta Region
      • Hohoe, Volta Region, Ghana, 00233
        • University of Health and Allied Sciences, Fred N. Binka School of Public Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Apparently healthy students in their second and third years of study at University of Health and Allied Sciences, Fred N. Binka School of Public Health
  • Females and males aged 18 - 25 years
  • Agree to remain in the study area for the 26-week period of the follow-up
  • Gives written informed consent

For female participants with childbearing potential:

  • No plan to get pregnant the next 7 months (Acceptance of the requirement to use a highly effective form of birth control (herein referred to as condom) effective from consenting until at least week 24 after the final intake of Investigational Product (Month 6 visit).

Exclusion Criteria:

  • Individuals taking routine micronutrient supplements
  • History of food allergies
  • Sensitivity to micronutrient supplement consumption and to any compositions of the micronutrients
  • For females of child-bearing potential: pregnant as per serum pregnancy testing, or planning to become pregnant.
  • Taking medications that could interact with the micronutrient supplements. Key medications which deplete the absorption of micronutrients include acid-suppressing and antacids, antiepileptic drugs (anti-convulsants), antibiotics, hormone replacement therapy (estrogens), digoxin, anti-inflammatory/analgesics
  • Interested persons with severe anaemia (hemoglobin less than 7g/dl), as identified in the screening phase, will not be enrolled in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Training and Active Ingredient Arm (Arm 1)
Particiants receive a daily Investigational Product for 24 weeks plus Nutrition Training and Healthy Lifestyle Coaching
Participants receive a daily sachet of effervescent powder that is Orange flavored, containing multiple vitamins and minerals
Participants receive Nutrition training and healthy lifestyle coaching
Active Comparator: Active Ingredient Arm (Arm 2)
Participants receive a daily active Investigational Product for 24 weeks
Participants receive a daily sachet of effervescent powder that is Orange flavored, containing multiple vitamins and minerals
Placebo Comparator: Placebo Arm (Arm 3)
Participants receive a daily placebo Investigational Product for 24 weeks
Participants receive a daily sachet of effervescent powder that is Orange flavored containing no active ingredients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with improved Vitamin D status
Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the vitamin D status of the study participants with or without additional Nutrition Training and Healthy Lifestyle Coaching. Thresholds for determining Vitamin D status are based on serum 25-hydroxyvitamin D levels.
From baseline to endpoint data collection, the time frame is 24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with improved vitamin B12 status
Time Frame: Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the status of Vitamin B12 of the study participants that will receive a micronutrient supplement with or without additional Nutrition Training and Healthy Lifestyle Coaching.
Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants with improved serum zinc status
Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the status of serum zinc of the study participants that will receive a micronutrient supplement with or without additional Nutrition Training and Healthy Lifestyle Coaching.
From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants with improved serum magnesium status
Time Frame: Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the status of serum magnesium of the study participants that will receive a micronutrient supplement with or without additional Nutrition Training and Healthy Lifestyle Coaching.
Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants with improved serum ferritin and red blood cell Haemoglobin status
Time Frame: Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the status of serum ferritin and red blood cell haemoglobin of the study participants that will receive a micronutrient supplement with or without additional Nutrition Training and Healthy Lifestyle Coaching.
Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants reporting effectiveness of additional Nutrition Training and Healthy Lifestyle Coaching on their lifestyle habits and overall well-being
Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
The effect of micronutrient supplementation with or without additional Nutrition Training and Healthy Lifestyle Coaching on participants' lifestyle habits and overall well- being will be measured through targeted questionnaires as per outcome 2. The following data collection tools are used: 1) Global physical activity questionnaire; 2) Lifestyles and Habits Questionnaire; 3) Depression Anxiety Stress Scale 21; 4) Short Item Form Survey; 5) Young Women Food Intake; 6) Food Insecurity Experience; 7) 7-day Dietary Habit Recall; 8) Non-alcoholic Sugar-Sweetened Beverage Intake; 9) Multidimensional Subjective Wellbeing (MSW); 10) Nutrition Training and Healthy Lifestyle questionnaire. Each questionnaire has a different scale. Each questionnaire will be evaluated separately...
From baseline to endpoint data collection, the time frame is 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Francis B. Prof. Zotor, PhD, University of Health and Allied Sciences, Fred N. Binka School of Public Health (FNBSPH), Ghana

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2025

Primary Completion (Actual)

August 26, 2025

Study Completion (Actual)

August 26, 2025

Study Registration Dates

First Submitted

February 15, 2025

First Submitted That Met QC Criteria

June 19, 2025

First Posted (Actual)

June 22, 2025

Study Record Updates

Last Update Posted (Estimated)

November 14, 2025

Last Update Submitted That Met QC Criteria

November 13, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • PACTR202402872415588
  • UHAS-REC L.7 16123-24 (Other Identifier: UHAS RESEARCH ETHICAL COMMITTEE (REC))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

A Data sharing agreement (but not a formal IDP plan) was signed giving access to other researchers for academic, non-commercial purposes. It stipulates:

  1. For the sole use of any and all academic, non-commercial research purposes, including communication and publication in scientific journals, the Sponsor grants the Chief Investigator and the Participating Institution a royalty-free, non-exclusive, worldwide, perpetual, non-transferable license to use all Data, suitably anonymized.
  2. The Chief Investigator, shall not and shall procure that the Participating Institutions shall not, give access to the Data to any commercial organisation other than the Sponsor and the Supporting Funder during the term of this Agreement and for a period of five years from the date of completion of the Study without the prior written consent of the Sponsor.
  3. The Sponsor and the Chief Investigator agree to inform in writing each other about all organisations to whom they grant access to the Data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Micronutrient Deficiencies

Clinical Trials on Active Effervescent Powder

Subscribe